{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:25:45Z","timestamp":1793330745282,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1999,11,1]],"date-time":"1999-11-01T00:00:00Z","timestamp":941414400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[1999,11]]},"DOI":"10.1038\/eye.1999.217","type":"journal-article","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T10:57:54Z","timestamp":1309777074000},"page":"729-733","source":"Crossref","is-referenced-by-count":106,"title":["Ocular toxicity in low-dose tamoxifen: A prospective study"],"prefix":"10.1038","volume":"13","author":[{"given":"Baha'N","family":"Noureddin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhieddin","family":"Seoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Bashshur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Shamseddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFeye1999217_CR1","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/251446a0","volume":"251","author":"JH Clark","year":"1974","unstructured":"Clark JH, Peck EJ Jr, Anderson JN . Oestrogen reception and antagonism of steroid hormone action. Nature 1974;251:446\u20138.","journal-title":"Nature"},{"key":"BFeye1999217_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0039-6257(89)90105-7","volume":"34","author":"PS Imperia","year":"1989","unstructured":"Imperia PS, Lazarus HM, Lass J . Ocular complications of systemic cancer chemotherapy. Surv Ophthalmol 1989;34:219\u201330.","journal-title":"Surv Ophthalmol"},{"key":"BFeye1999217_CR3","first-page":"499","volume":"25","author":"S Sananes","year":"1996","unstructured":"Sananes S, Khairallah T, Touboul E, Salat-Baroux J, Uzan S . A surveillance of patients treated with tamoxifen. Presse Med 1996;25:499\u2013502.","journal-title":"Presse Med"},{"key":"BFeye1999217_CR4","first-page":"165","volume":"82","author":"M Seoud","year":"1993","unstructured":"Seoud M, Johnson J, Weed JC . Gynecologic tumors in tamoxifen-treated women with breast cancer. Obstet Gynaecol 1993;82:165\u20139.","journal-title":"Obstet Gynaecol"},{"key":"BFeye1999217_CR5","first-page":"315","volume":"62","author":"MI Kaiser-Kupfer","year":"1978","unstructured":"Kaiser-Kupfer MI, Lippman ME . Tamoxifen retinopathy. Cancer Treat Rep 1978;62:315\u201320.","journal-title":"Cancer Treat Rep"},{"key":"BFeye1999217_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/bjo.65.3.177","volume":"65","author":"CA McKeown","year":"1981","unstructured":"McKeown CA, Swart ZM, Bloom J, Maggiano JM . Tamoxifen retinopathy. Br J Ophthalmol 1981;65:177\u20139.","journal-title":"Br J Ophthalmol"},{"key":"BFeye1999217_CR7","first-page":"420","volume":"21","author":"EW Gerner","year":"1989","unstructured":"Gerner EW . Ocular toxicity of tamoxifen. Ann Ophthalmol 1989;21:420\u20133.","journal-title":"Ann Ophthalmol"},{"key":"BFeye1999217_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/bmj.304.6825.495","volume":"304","author":"CR Bentley","year":"1992","unstructured":"Bentley CR, Davies G, Aclimandos WA . Tamoxifen retinopathy: a rare but serious complication. BMJ 1992;304:495\u20136.","journal-title":"BMJ"},{"key":"BFeye1999217_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1755-3768.1983.tb01393.x","volume":"61","author":"T Vinding","year":"1983","unstructured":"Vinding T, Nielsen NV . Retinopathy caused by treatment with tamoxifen in low dose. Acta Ophthalmol (Copenh) 1983;61:45\u201350.","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"BFeye1999217_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0002-9394(87)90014-6","volume":"104","author":"M Griffiths","year":"1987","unstructured":"Griffiths M . Tamoxifen retinopathy at low dosage. Am J Ophthalmol 1987;104:185\u20136.","journal-title":"Am J Ophthalmol"},{"key":"BFeye1999217_CR11","first-page":"148","volume":"27","author":"T Chang","year":"1992","unstructured":"Chang T, Gonder JR, Ventresco MR . Low-dose tamoxifen retinopathy. Can J Ophthalmol 1992;27:148\u20139.","journal-title":"Can J Ophthalmol"},{"key":"BFeye1999217_CR12","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S0002-9394(14)71357-1","volume":"116","author":"S Chern","year":"1993","unstructured":"Chern S, Danis R . Retinopathy associated with low-dose tamoxifen. Am J Ophthalmol 1993;116:372\u20133.","journal-title":"Am J Ophthalmol"},{"key":"BFeye1999217_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/1097-0142(19860715)58:2<383::AID-CNCR2820580232>3.0.CO;2-I","volume":"58","author":"T Pugesgaard","year":"1986","unstructured":"Pugesgaard T, Von Eyben FE . Bilateral optic neuritis evolved during tamoxifen treatment. Cancer 1986;58:383\u20136.","journal-title":"Cancer"},{"key":"BFeye1999217_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/1097-0142(19880101)61:1<33::AID-CNCR2820610107>3.0.CO;2-I","volume":"61","author":"AR Ashford","year":"1988","unstructured":"Ashford AR, Done VI, Tiwari RP, Garett TJ . Reversible ocular toxicity related to tamoxifen therapy. Cancer 1988;61:33\u20135.","journal-title":"Cancer"},{"key":"BFeye1999217_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/112067219500500406","volume":"5","author":"R Thersson","year":"1995","unstructured":"Thersson R, Jansen E, Leys A, Rutten J, Meyskens J . Screening for tamoxifen ocular toxicity: a prospective study. Eur J Ophthalmol 1995;5:230\u20134.","journal-title":"Eur J Ophthalmol"},{"key":"BFeye1999217_CR16","first-page":"1833","volume":"63","author":"M Beck","year":"1979","unstructured":"Beck M, Mills PV . Ocular assessment of patients treated with tamoxifen. Cancer Treat Rep 1979;63:1833\u20134.","journal-title":"Cancer Treat Rep"},{"key":"BFeye1999217_CR17","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/0277-5379(89)90351-9","volume":"25","author":"S Longstaff","year":"1989","unstructured":"Longstaff S, Sigurdsson H, O'Keeffe M, Ogston S, Preece P . A controlled study of the ocular effects of tamoxifen in conventional dosage in the treatment of breast carcinoma. Eur J Cancer Clin Oncol 1989;25:1805\u20138.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BFeye1999217_CR18","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/S0002-9394(14)70321-6","volume":"117","author":"J Heier","year":"1994","unstructured":"Heier J, Dragoo R, Enzenauer R, Waterhouse W . Screening for ocular toxicity in asymptomatic patients treated with tamoxifen. Am J Ophthalmol 1994;117:772\u20135.","journal-title":"Am J Ophthalmol"},{"key":"BFeye1999217_CR19","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1002\/1097-0142(19920615)69:12<2961::AID-CNCR2820691215>3.0.CO;2-W","volume":"69","author":"NA Palvidis","year":"1992","unstructured":"Palvidis NA, Petris C, Braissoulis, et al. Clear evidence that long-term, low dose tamoxifen treatment can induce ocular toxicity. Cancer 1992;69:2961\u20134.","journal-title":"Cancer"},{"key":"BFeye1999217_CR20","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1200\/JCO.1996.14.3.1018","volume":"14","author":"SG Nayfield","year":"1996","unstructured":"Nayfield SG, Gorin MB . Tamoxifen-associated eye disease: a review. J Clin Oncol 1996;14:1018\u201326.","journal-title":"J Clin Oncol"},{"key":"BFeye1999217_CR21","first-page":"583","volume":"59","author":"PE Schwartz","year":"1982","unstructured":"Schwartz PE, Keating G, MacLusky N . Tamoxifen therapy for advanced ovarian cancer. Obstet Gynecol 1982;59:583\u20138.","journal-title":"Obstet Gynecol"},{"key":"BFeye1999217_CR22","first-page":"335","volume":"12","author":"MC Crowson","year":"1986","unstructured":"Crowson MC, Dorrel A, Rolfe EB, Fielding JWL . A phase II study to evaluate tamoxifen in pancreatic adenocarcinoma. Eur J Surg Oncol 1986;12:335\u20136.","journal-title":"Eur J Surg Oncol"},{"key":"BFeye1999217_CR23","first-page":"69","volume":"12","author":"K Tonnesen","year":"1986","unstructured":"Tonnesen K, Kamp-Jensen M . Antiestrogen therapy in pancreatic carcinoma: a preliminary report. Eur J Surg Oncol 1986;12:69\u201370.","journal-title":"Eur J Surg Oncol"},{"key":"BFeye1999217_CR24","first-page":"171","volume":"64","author":"FL Meyskens","year":"1980","unstructured":"Meyskens FL Jr, Voakes JB . Tamoxifen in metastatic malignant melanoma. Cancer Treat Rep 1980;64:171\u20133.","journal-title":"Cancer Treat Rep"},{"key":"BFeye1999217_CR25","first-page":"203","volume":"3","author":"BS Kramer","year":"1993","unstructured":"Kramer BS, Brawley OW, Nayfield S, et al. NCI studies in primary prevention of breast and prostatic cancer. Cancer Res Ther Control 1993;3:203\u201311.","journal-title":"Cancer Res Ther Control"},{"key":"BFeye1999217_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/10408447509164014","volume":"4","author":"H Lullman","year":"1975","unstructured":"Lullman H, Lullman-Rauch R, Wasserman O . Drug induced phospholipidoses. Crit Rev Toxicol 1975;4:185\u2013218.","journal-title":"Crit Rev Toxicol"},{"key":"BFeye1999217_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0161-6420(81)35071-4","volume":"88","author":"MI Kaiser-Kupfer","year":"1981","unstructured":"Kaiser-Kupfer MI, Kupfer C, Rodrigues MM . Tamoxifen retinopathy: a clinicopathologic report. Ophthalmology 1981;88:89\u201393.","journal-title":"Ophthalmology"},{"key":"BFeye1999217_CR28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/0041-008X(81)90014-4","volume":"61","author":"H Lullman","year":"1981","unstructured":"Lullman H, Lullman-Rauch R . Tamoxifen induced generalized lipidosis in rats subchronically treated with high doses. Toxicol Appl Pharmacol 1981;61:138\u201346.","journal-title":"Toxicol Appl Pharmacol"},{"key":"BFeye1999217_CR29","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/0014-4800(78)90010-2","volume":"28","author":"D Drenckhahn","year":"1978","unstructured":"Drenckhahn D, Lullman-Rauch R . Drug induced retinal lipidosis: differential susceptibilities of pigment epithelium and neuroretina toward several amphilic cationic drugs. Exp Mol Pathol 1978;28:360\u201371.","journal-title":"Exp Mol Pathol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye1999217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye1999217","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye1999217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:56:39Z","timestamp":1684428999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye1999217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1999,11]]}},"alternative-id":["BFeye1999217"],"URL":"https:\/\/doi.org\/10.1038\/eye.1999.217","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,11]]}}}